ReviewBiomedical reports2025
Mechanism of influence of calcified nanoparticles in the development of calcified diseases (Review).
Review in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanobacterial detection in aqueous humor and its effect on postphacoemulsification visual acuity among highly myopic patients.Molecular vision · 2026Article
- Prevalence of Pulp Stones on Panoramic Radiographs in Patients with Chronic Systemic Diseases: A Cross-sectional Study.Rambam Maimonides medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcified nanoparticles (CNPs), also known as nanobacteria, are ubiquitously present in both natural minerals and biological systems. However, their properties remain incompletely elucidated, particularly concerning whether they represent the smallest self-replicating entities on Earth, a topic that remains highly debated. Current research has demonstrated that CNPs can be isolated from various pathological calcification conditions, including kidney stones, vascular calcification, biliary stones, and calculus oral disease. These particles have the potential to infect any tissue or cell type within the human body, forming a mineralized layer around them, which leads to pathological calcification of tissues. It is suggested that CNPs may play a significant role in these diseases by damaging cells, promoting osteogenic differentiation, and influencing metabolic processes, thereby initiating the formation of calcification cores in local tissues. Under the influence of inflammatory responses, these cores can expand further, ultimately leading to the development of calcification diseases. Therefore, the aim of the present review was to explore the roles and pathogenic mechanisms of CNPs in various pathological calcification diseases, providing new insights for in-depth research into their properties and pathogenic mechanisms, as well as identifying potential therapeutic targets for calcification diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.